We invite external agencies, groups and individuals to request endorsement of educational or clinical programs and materials related to cancer, cancer care or nursing.
The following are examples of programs and materials eligible for CANO/ACIO endorsement:
- educational seminars, workshops, conferences
- independent study packages
- educational videotapes or audio tapes
- electronic media, such as CDs, DVDs, podcasts, and educational web site
- patient or public education materials
- oncology courses at community college, university, etc.
- clinical assessment tools
- clinical guidelines
Programs and materials developed by CANO/ACIO leaders in keeping with the mission of the Association under the guidance of the Board of Directors are normally endorsed as a Board decision and exempt from this policy.
Letters of support for research proposals being made by CANO/ACIO members to funding bodies are normally exempt from this policy. Such letters will be considered where proposed studies have direct relevance to the advancement of oncology nursing in Canada in keeping with the strategic directions set by the CANO/ACIO Board as determined by the Director at Large for Research and theCANO/ACIO President.
Below are some of our current endorsements.
PEER stands for Pediatric cancer patients and survivors Engaging in Exercise for Recovery. Developed by Dr. Carolina Chamorro Vina, PhD and a multidisciplinary team of pediatric oncology specialists from the University of Calgary and the Alberta Children's Hospital, PEER is a research-based exercise program designed to help pediatric oncology patients and survivors engage in physical activity, and ease the long-term impact of cancer and its treatment through exercise.
Recognizing and Addressing Immune-Related Adverse Events: Key Strategies to Optimize Patient Outcomes With Immunotherapy
As immunotherapy-based approaches become integrated into standard clinical oncology practice, there is an increased need for all medical oncology team members to be able to recognize and manage IRAEs in patients with solid tumours receiving immunotherapy. This activity comprises 2 presentations.
The first presentation will outline the growing role of immunotherapy in oncology and key differences in the safety profiles of immunotherapies versus traditional chemotherapy.
The second presentation will discuss the optimal management of IRAEs, including organ specific AEs, and the need to address these events early, to prevent progression. Strategies to optimize multidisciplinary care will also be discussed.
EMBRACE: Role of Targeted Therapy in Metastatic Breast Cancer
EMBRACE is a brand new MBC learning program designed by an engaged and highly experienced Steering Committee of fellow oncology nurses. Understanding the targeted audience for this program are busy and expected to stay up-to-date with the latest treatment options to optimally support their patients, EMBRACE was built with flexible modules to allow for short or in-depth discussions.
The program includes an overview of MBC, clinical evidence for available treatment options, and opportunities for reflection on clinical practice, using case-based learning techniques.
Last Updated: December 3, 2019